Volume Growth
18.5%
+18.5pp YoY
Test volume growth for Q4 FY26, driven by pathology and radiology segments.
VIJAYADIAGNOSTICCENTRE
Other
15 May 2026
Vijaya Diagnostic Centre Limited — Q4 FY26
Vijaya Diagnostic delivered a strong Q4 FY26 with revenue of ₹219 crore (+26.6% YoY) and EBITDA margin of 43.5% (+379bps YoY), driven by 18.5% volume growth and favorable seasonality.
✓ Verified against BSE filing
2-Min Summary
Vijaya Diagnostic delivered a strong Q4 FY26 with revenue of ₹219 crore (+26.6% YoY) and EBITDA margin of 43.5% (+379bps YoY), driven by 18.5% volume growth and favorable seasonality. The wellness segment and Hyderabad market (20% growth) were key contributors. PAT stood at ₹47.9 crore (+37.5% YoY). Management guided for 40%+ EBITDA margins in FY27 despite new center investments, with capex of ₹140-150 crore for 4-5 hubs and 10-12 spokes. The automated lab in Punjagutta and genomic testing are new initiatives. Risk: competitive intensity from hospital labs and online aggregators could pressure pricing and market share.
Key Numbers
Revenue per Test
₹488
+4.3% YoY
Increase due to change in test mix from new hubs ramping up.
Revenue per Footfall
₹1,808
+8.1% YoY
Driven by wellness segment growth and favorable seasonality.
B2C Revenue Share
92%
flat YoY
Consistent B2C focus, with radiology contributing 37% of revenue.
Management Guidance
FY27 EBITDA margin guidance of 40%+
Management expects to deliver over 40% EBITDA margin despite new center investments and technology/talent costs.
marginsCapex of ₹140-150 crore for FY27
Includes 4-5 hubs, 10-12 spokes, and an automated lab in Punjagutta, Hyderabad.
capexDouble-digit revenue growth in Pune for FY27
Confident of double-digit growth in Pune for the full year, driven by network expansion and corporate segment.
growthPrice hike of 1-1.5% in Q1 or Q2 FY27
Selective price increases on certain tests, similar to previous year.
revenueKey Risks
Competition from hospital labs and online aggregators
Hospital labs and online players could pressure pricing and market share, especially in new geographies.
medium · analyst_questionExecution risk in new geographies
Rapid expansion into Bangalore, Kolkata, and Pune may face operational challenges and slower-than-expected ramp-up.
medium · management_commentaryCapex intensity and cash deployment
High capex of ₹140-150 crore may strain cash flows if expansion opportunities exceed planned leases.
low · data_observationNotable Quotes
We are very confident that in next 3 to 5 years we'll be easily doubling up our revenue from where we are now.
We are with growth while opening new centers we'll still be delivering 40% plus EBITDA margins.
The denser we grow into Kolkata, in West Bengal and into Pune, this is probably going to just get better.